Nestlé has agreed to sell its mainstream Vitamins, Minerals and Supplements business—marketed as the Holistic Health portfolio—to an undisclosed private equity firm for $1 billion in cash. The deal, announced Monday, marks the Swiss food conglomerate's withdrawal from a category it entered through acquisition more than a decade ago but never scaled to market leadership.

The divested unit includes mass-market supplement brands distributed primarily through retail pharmacy and grocery channels in North America and Europe. Nestlé disclosed the buyer but did not name the private equity firm, suggesting either a middle-market fund or a pending announcement from a portfolio company platform. The transaction is expected to close in the second half of 2025, subject to regulatory clearance. Nestlé will retain its premium medical nutrition brands and infant formula lines, which carry higher margins and tighter hospital distribution relationships.

The exit reflects a strategic pivot under CEO Laurent Freixe, who took the role in September 2023 and has since divested $2.8 billion in non-core assets. Nestlé's VMS business generated roughly $600 million in annual revenue but operated at sub-group EBITDA margins, dragged down by promotional intensity in the U.S. mass channel and declining consumer trust in mainstream supplement efficacy. The sale price implies a 1.67x revenue multiple—below the 2.0-2.5x range where branded consumer health assets typically trade, signaling either margin pressure or portfolio composition weighted toward commoditized SKUs. The $1 billion in proceeds will likely flow into debt reduction or share buybacks, given Nestlé's elevated net debt position of CHF 24 billion as of Q4 2024.

Allocators should note two second-order effects. First, the buyer—likely a healthcare-focused PE firm—will attempt operational restructuring around direct-to-consumer channels and potentially bolt-on acquisitions in personalized nutrition or functional supplements, where growth rates remain in the mid-teens. Second, this sale accelerates category consolidation. With Nestlé exiting, Church & Dwight, Haleon, and private-label manufacturers now control 82% of U.S. mass-market VMS shelf space. Pricing power shifts further toward retail buyers, compressing supplier margins unless brands migrate to specialty or online channels.

Watch for three follow-on events. The private equity buyer will surface within 30 days if the deal structure includes financing that requires disclosure. Nestlé's H1 2025 earnings call in late July will clarify whether additional portfolio pruning is planned—the company still holds underperforming water brands and regional confectionery lines. Finally, competitor M&A activity in adjacent categories—probiotics, collagen peptides, nootropics—should accelerate as PE shops deploy record dry powder into consumer health.

Nestlé's consumer health revenue mix is now 91% core food and beverage, 9% medical nutrition. The VMS business never exceeded 4% of group sales.